Logo

American Heart Association

  9
  0


Final ID: Su2171

Hemodynamic Indices of Right Ventricular Function Differentially Predict Adverse Clinical Outcomes in Heart Failure with Preserved vs Reduced Ejection Fraction

Abstract Body (Do not enter title and authors here):
Background: While the critical role of right ventricular dysfunction (RVD) in heart failure (HF) is increasingly recognized, the prevalence and prognostic impact of RVD across HF subtypes is poorly understood.

Research Questions/Aims: We aimed to characterize differences in hemodynamic indices of RV function among patients with HF with preserved vs reduced ejection fraction (HFpEF, EF≥50% vs HFrEF, EF<50%) and to examine associations of RVD with longitudinal clinical outcomes by HF subtype.

Methods: We identified patients with prevalent HF undergoing clinically indicated right heart catheterization at Massachusetts General Hospital (2005-2016). We examined three RV hemodynamic indices: right atrial to wedge pressure ratio (RA/PCWP), RV stroke work index (RVSWI), and pulmonary artery pulsatility index (PAPi). We used multivariable linear regression to assess differences in RV indices in HFpEF vs HFrEF. We then used Cox models to examine the association of each index with HF hospitalizations (HFH), major adverse cardiac events (MACE), and death, stratified by HF subtype. Models were adjusted for age, sex, BMI, hypertension, diabetes, lung disease, sleep apnea, and prior MI.

Results: Of 2,062 patients (age 66 years, 33% women), 1,242 (60%) had HFrEF and 820 (40%) had HFpEF. RVD (RVSWI <450 mm Hg*ml/m2) was present in 27% of HFrEF vs 21% of HFpEF patients. Those with HFpEF had higher RA/PCWP (β 0.12, SE 0.05, p=0.012) and RVSWI (β 0.22, SE 0.05, p<0.001) relative to HFrEF. Over 4.1 median years follow-up, 915 HFH, 1,066 MACE, and 1,116 death events occurred. Among those with HFrEF, lower PAPi was associated with greater risk of HFH (HR 0.84 (0.77, 0.92); p<0.001) and MACE (HR 0.88 (0.81, 0.96); p=0.003), and higher RVSWI was associated with greater risk of death (HR 1.17, (1.07, 1.27); p<0.001, Figure). In contrast, in those with HFpEF, only higher RA/PCWP was associated with greater risk of death (HR 1.11 (1.00, 1.23); p=0.042).

Conclusion: RVD occurs frequently in both HFrEF and HFpEF, and hemodynamic measures of RV function are associated with greater risk of MACE, death, and HFH. Importantly, the prognostic value of RV indices varied by HF subtype, highlighting key differences in the role of RVD in HFrEF vs HFpEF.
  • Kosyakovsky, Leah  ( Beth Israel Deaconess , Boston , Massachusetts , United States )
  • Parekh, Juhi  ( Beth Israel Deaconess , Boston , Massachusetts , United States )
  • Zern, Emily  ( Los Angeles General Medical Center , Los Angeles , California , United States )
  • Mcneill, Jenna  ( Duke University , Durham , North Carolina , United States )
  • Pomerantsev, Eugene  ( Massachusetts General Hospital , Boston , Massachusetts , United States )
  • Picard, Michael  ( Massachusetts General Hospital , Boston , Massachusetts , United States )
  • Dudzinski, David  ( Massachusetts General Hospital , Boston , Massachusetts , United States )
  • Lau, Emily  ( Massachusetts General Hospital , Boston , Massachusetts , United States )
  • Ho, Jennifer  ( Beth Israel Deaconess , Boston , Massachusetts , United States )
  • Author Disclosures:
    Leah Kosyakovsky: DO NOT have relevant financial relationships | Juhi Parekh: DO NOT have relevant financial relationships | Emily Zern: DO NOT have relevant financial relationships | Jenna McNeill: No Answer | Eugene Pomerantsev: DO NOT have relevant financial relationships | Michael Picard: DO have relevant financial relationships ; Consultant:Techtonic Therapeutic:Active (exists now) ; Consultant:Vertex Pharmaceuticals:Active (exists now) | David Dudzinski: DO NOT have relevant financial relationships | Emily Lau: DO have relevant financial relationships ; Advisor:Astellas Pharma:Past (completed) | Jennifer Ho: DO have relevant financial relationships ; Individual Stocks/Stock Options:Pfizer:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Frontiers in HFpEF Part 1: Echocardiography and Hemodynamic Findings

Sunday, 11/17/2024 , 11:30AM - 12:30PM

Abstract Poster Session

More abstracts on this topic:
Association Between Right Ventricular-Pulmonary Arterial Coupling and Outcomes in Patients with Heart Failure with Preserved Ejection Fraction

Sherafati Alborz, Dragomirescu Catalin, Brewster Pamela, Kennedy David, Gupta Rajesh, Khouri Samer, Kloster Alex, Manandhar Sareeta, Fares Anas, Aradhyula Vaishnavi, Dube Prabhatchandra, Elzanaty Ahmed, Sajdeya Omar, Khatib-shahidi Bella

A Rare Cause of Recurrent Heart Failure Exacerbations After Transcatheter Aortic Valve Replacement: Ventricular Septal Defect and Significant Paravalvular Leak

Medina Jesse, Vincent Louis, Rodriguez Ferreira Esteban, Spence-miller Shanice, Fernandez Joel, Colombo Rosario, Calfa Marian

More abstracts from these authors:
A Deep Learning Digital Biomarker for Mitral Valve Prolapse using Echocardiogram Videos

Al-alusi Mostafa, Khurshid Shaan, Sanborn Danita, Picard Michael, Ho Jennifer, Maddah Mahnaz, Ellinor Patrick, Lau Emily, Small Aeron, Reeder Christopher, Shnitzer Dery Tal, Andrews Carl, Kany Shinwan, Ramo Joel, Haimovich Julian

Association of Eicosanoid Metabolites with Body Mass Index

Chitsazan Mandana, Ho Jennifer, Parekh Juhi, Lau Emily, Alotaibi Mona, Yu Bing, Allen Norrina, Allison Matthew, Jain Mohit, Cheng Susan

You have to be authorized to contact abstract author. Please, Login
Not Available